UTAH MEDICAL PRODUCTS, INC. (UTMD) Current Ratio
- Current ratio · latest quarter: Value 48.62×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 48.62× | Current assets / current liabilities. $100.64M ÷ $2.07M ≈ 48.62× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 100.64M USD | Assets, Current |
| Current obligations | 2.07M USD | Liabilities, Current |
| Cash and equivalents | 87.53M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 3.56M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 9.00M USD | Inventory, Net |
| Payables | 876.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $100.64M | $2.07M | $87.53M | (m) | $3.56M | $9.00M | $876.00K | (m) | 48.62× |
| 2026-03-31 | $100.38M | $3.50M | $87.41M | (m) | $3.64M | $8.72M | $1.19M | (m) | 28.64× |
| 2025-12-31 | $97.74M | $2.60M | $85.76M | (m) | $3.52M | $7.93M | $911.00K | (m) | 37.62× |
| 2025-09-30 | $96.53M | $3.01M | $84.27M | (m) | $3.73M | $8.12M | $768.00K | (m) | 32.06× |
| 2025-06-30 | $94.38M | $2.25M | $82.18M | (m) | $3.63M | $8.23M | $737.00K | (m) | 41.87× |
| 2025-03-31 | $96.40M | $4.32M | $83.33M | (m) | $3.94M | $8.65M | $914.00K | (m) | 22.29× |
| 2024-12-31 | $96.33M | $3.76M | $82.98M | (m) | $4.09M | $8.81M | $696.00K | (m) | 25.64× |
| 2024-09-30 | $101.66M | $3.44M | $88.45M | (m) | $3.72M | $9.11M | $999.00K | (m) | 29.59× |
| 2024-06-30 | $102.32M | $3.94M | $89.22M | (m) | $3.67M | $9.06M | $834.00K | (m) | 25.98× |
| 2024-03-31 | $107.15M | $5.47M | $93.81M | (m) | $3.59M | $9.24M | $998.00K | (m) | 19.57× |
| 2023-12-31 | $106.27M | $4.71M | $92.87M | (m) | $3.39M | $9.58M | $769.00K | (m) | 22.56× |
| 2023-09-30 | $101.85M | $4.18M | $88.21M | (m) | $3.49M | $9.71M | $511.00K | (m) | 24.38× |
| 2023-06-30 | $98.81M | $5.14M | $84.62M | (m) | $3.60M | $10.12M | $1.34M | (m) | 19.21× |
| 2023-03-31 | $95.11M | $6.07M | $80.91M | (m) | $3.82M | $9.94M | $1.03M | (m) | 15.66× |
| 2022-12-31 | $89.92M | $5.96M | $75.05M | (m) | $5.54M | $8.81M | $1.22M | (m) | 15.09× |
| 2022-09-30 | $84.24M | $6.27M | $69.51M | (m) | $6.03M | $8.31M | $1.29M | (m) | 13.44× |
| 2022-06-30 | $78.95M | $4.44M | $66.22M | (m) | $4.94M | $7.34M | $818.00K | (m) | 17.79× |
| 2022-03-31 | $79.48M | $6.10M | $65.87M | (m) | $5.72M | $7.37M | $1.45M | (m) | 13.03× |
| 2021-12-31 | $73.16M | $3.75M | $60.97M | (m) | $5.13M | $6.60M | $761.00K | (m) | 19.53× |
| 2021-09-30 | $75.85M | $5.01M | $64.32M | (m) | $4.85M | $6.30M | $1.03M | (m) | 15.12× |
| 2021-06-30 | $70.59M | $4.43M | $59.51M | (m) | $4.61M | $6.12M | $1.19M | (m) | 15.93× |
| 2021-03-31 | $66.62M | $4.57M | $56.03M | (m) | $4.16M | $5.97M | $839.00K | (m) | 14.59× |
| 2020-12-31 | $62.26M | $3.79M | $51.59M | (m) | $4.10M | $6.22M | $788.00K | (m) | 16.42× |
| 2020-09-30 | $57.26M | $3.63M | $46.29M | (m) | $4.28M | $6.30M | $651.00K | (m) | 15.79× |
| 2020-06-30 | $53.12M | $3.24M | $42.35M | (m) | $3.79M | $6.58M | $560.00K | (m) | 16.38× |
| 2020-03-31 | $51.22M | $3.80M | $39.61M | (m) | $4.41M | $6.76M | $1.06M | (m) | 13.48× |
| 2019-12-31 | $54.89M | $3.45M | $42.79M | (m) | $4.74M | $6.91M | $1.10M | (m) | 15.92× |
| 2019-09-30 | $49.51M | $3.69M | $37.39M | (m) | $5.07M | $6.71M | $785.00K | (m) | 13.43× |
| 2019-06-30 | $46.23M | $3.82M | $32.88M | (m) | $5.24M | $7.71M | $854.00K | (m) | 12.10× |
| 2019-03-31 | $45.67M | $7.04M | $32.66M | (m) | $4.91M | $7.65M | $2.85M | (m) | 6.48× |
| 2018-12-31 | $60.90M | $5.26M | $51.11M | (m) | $3.96M | $5.41M | $975.00K | (m) | 11.58× |
| 2018-09-30 | $59.05M | $4.77M | $49.35M | (m) | $4.48M | $4.92M | $668.00K | (m) | 12.38× |
| 2018-06-30 | $56.00M | $5.25M | $45.87M | (m) | $4.53M | $5.23M | $979.00K | (m) | 10.67× |
| 2018-03-31 | $53.12M | $5.12M | $42.85M | (m) | $4.21M | $5.56M | $1.08M | (m) | 10.37× |
| 2017-12-31 | $49.19M | $5.28M | $39.88M | (m) | $3.62M | $5.24M | $934.00K | (m) | 9.32× |
| 2017-09-30 | $48.02M | $5.18M | $37.44M | (m) | $4.73M | $5.04M | $1.13M | (m) | 9.27× |
| 2017-06-30 | $43.79M | $4.39M | $33.74M | (m) | $4.47M | $4.80M | $984.00K | (m) | 9.97× |
| 2017-03-31 | $40.52M | $5.37M | $30.68M | (m) | $4.18M | $4.76M | $1.02M | (m) | 7.55× |
| 2016-12-31 | $34.47M | $3.02M | $26.30M | (m) | $3.21M | $4.54M | $906.00K | (m) | 11.41× |
| 2016-09-30 | $41.90M | $5.53M | $31.56M | (m) | $5.03M | $4.53M | $943.00K | (m) | 7.58× |
| 2016-06-30 | $39.22M | $5.18M | $29.39M | (m) | $4.98M | $4.10M | $1.06M | (m) | 7.57× |
| 2016-03-31 | $38.27M | $6.33M | $27.52M | (m) | $5.40M | $4.49M | $978.00K | (m) | 6.04× |
| 2015-12-31 | $32.87M | $4.07M | $23.28M | (m) | $4.56M | $4.20M | $649.00K | (m) | 8.08× |
| 2015-09-30 | $32.31M | $5.74M | $21.62M | (m) | $5.49M | $4.45M | $922.00K | (m) | 5.63× |
| 2015-06-30 | $29.98M | $5.33M | $19.17M | (m) | $5.61M | $4.47M | $932.00K | (m) | 5.62× |
| 2015-03-31 | $26.79M | $5.36M | $16.10M | (m) | $5.01M | $4.85M | $807.00K | (m) | 5.00× |
| 2014-12-31 | $29.68M | $8.97M | $19.27M | (m) | $4.70M | $4.87M | $929.00K | (m) | 3.31× |
| 2014-09-30 | $28.58M | $9.16M | $18.25M | (m) | $4.65M | $4.87M | $1.02M | (m) | 3.12× |
| 2014-06-30 | $27.42M | $8.85M | $15.94M | (m) | $5.45M | $5.30M | $877.00K | (m) | 3.10× |
| 2014-03-31 | $26.33M | $8.55M | $15.04M | (m) | $5.08M | $5.29M | $758.00K | (m) | 3.08× |
| 2013-12-31 | $24.29M | $7.61M | $14.39M | (m) | $4.33M | $4.70M | $773.00K | (m) | 3.19× |
| 2013-09-30 | $24.53M | $9.23M | $13.87M | (m) | $4.96M | $4.66M | $1.21M | (m) | 2.66× |
| 2013-06-30 | $22.29M | $8.61M | $11.38M | (m) | $5.67M | $4.37M | $942.00K | (m) | 2.59× |
| 2013-03-31 | $21.60M | $9.02M | $10.87M | (m) | $5.36M | $4.41M | $1.14M | (m) | 2.39× |
| 2012-12-31 | $18.54M | $7.82M | $8.87M | (m) | $4.34M | $4.35M | $1.00M | (m) | 2.37× |
| 2012-09-30 | $20.06M | $11.41M | $9.29M | (m) | $5.04M | $4.71M | $1.18M | (m) | 1.76× |
| 2012-06-30 | $18.65M | $10.75M | $7.91M | (m) | $5.09M | $4.83M | $1.35M | (m) | 1.74× |
| 2012-03-31 | $19.99M | $11.80M | $8.16M | (m) | $6.07M | $4.83M | $1.25M | (m) | 1.69× |
| 2011-12-31 | $17.02M | $9.63M | $6.53M | (m) | $4.73M | $5.00M | $925.00K | (m) | 1.77× |
| 2011-09-30 | $17.74M | $10.49M | $7.04M | (m) | $5.03M | $4.96M | $1.70M | (m) | 1.69× |
| 2011-06-30 | $17.06M | $9.96M | $6.27M | (m) | $4.96M | $5.02M | $2.00M | (m) | 1.71× |
| 2010-12-31 | $25.14M | $1.90M | $3.82M | (m) | $3.16M | $3.10M | $398.00K | (m) | 13.21× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |